Understanding patient experiences of Asian cancer patients at MD Anderson
Understanding Patient Experience Among Asians at MD Anderson
M.D. Anderson Cancer Center · NCT06259253
This study is trying to understand the experiences of Asian cancer patients at MD Anderson to see what helps or hinders their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 520 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center (other) |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06259253 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the barriers and facilitators that affect the patient experience of Asian and Asian American individuals diagnosed with cancer at MD Anderson Cancer Center. The primary objective is to identify key aspects of inpatient experiences among former patients, while secondary objectives focus on understanding healthcare providers' perceptions of these experiences. The study will involve interviews and surveys with former patients and healthcare providers to gather qualitative data on their experiences and insights.
Who should consider this trial
Good fit: Ideal candidates include Asian or Asian American individuals aged 18 and older who have been diagnosed with any type of cancer and received inpatient care at MD Anderson between 2019 and 2022.
Not a fit: Patients who do not identify as Asian or Asian American or who have not received inpatient care at MD Anderson during the specified timeframe may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved patient care and tailored support for Asian cancer patients.
How similar studies have performed: While there may be studies focusing on patient experiences in general, this specific focus on Asian cancer patients is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria for former patients: * Self-identify as Asian/Asian American * Are 18 years or older * Have been diagnosed with cancer, any type * Received inpatient care at MD Anderson between 2019 and 2022 * Have a U.S. address * Can read and write in English or simplified Chinese Exclusion criteria for former patients: • None Inclusion criteria for healthcare providers: * Self-report as a practicing provider at MD Anderson * Provided treatment services to Asian/Asian American patients between 2019 and 2022 Exclusion criteria for healthcare providers: • None
Where this trial is running
Houston, Texas
- MD Anderson Cancer Center — Houston, Texas, United States (RECRUITING)
Study contacts
- Principal investigator: Lorna McNeill, MPH,PHD — M.D. Anderson Cancer Center
- Study coordinator: Lorna McNeill, MPH,PHD
- Email: lmcneill@mdanderson.org
- Phone: (713) 563-1103
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer